CDTNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CDTTW

CDT Equity Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$0.19−0.05 (-20.88%)

Close on Oct 19, 2026

Market cap: $99.14K
P/E (TTM): –
Dividend yield: –

CDT Equity Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash & Equivalents	1.51	0.55	4.23	0.35	0.05
Short-Term Investments	–	0.60	4.20	–	–
Cash & Short-Term Investments	1.50	0.60	8.43	0.35	0.05
Prepaid Expenses & Other	1.82	1.78	1.51	0.30	0.06
Total Current Assets	4.38	2.72	5.73	0.65	0.10
Property, Plant & Equipment	0.27	0.04	–	–	–
Operating Lease Right-of-Use Assets	0.14	0.26	–	–	–
Intangible Assets	–	–	–	0.01	–
Total Assets	5.65	4.19	7.22	0.01	0.21
Accounts Payable	1.91	1.43	0.22	–	–
Accrued Expenses	9.60	–	–	0.04	0.02
Current Portion of Leases	0.12	0.12	–	–	–
Current Income Taxes Payable	–	–	–	0.37	–
Deferred Revenue (Current)	–	–	–	4.08	–
Total Current Liabilities	13	11	1.80	4.18	0.19
Long-Term Leases	–	0.11	–	–	–
Operating Lease Liabilities	0.12	0.23	–	–	–
Total Liabilities	13	11	7.68	10	0.19
Common Stock	–	0.01	0.01	0.01	–
Additional Paid-In Capital	61	22	10	–	0.02
Retained Earnings	-68	-29	-11	-11	0.00
Comprehensive Income & Other	-0.02	0.41	0.41	0.68	–
Shareholders' Equity	-7.17	-6.79	-0.46	-10	-5.96
Total Equity	-7.17	-6.79	-0.46	-10	-5.96
Total Liabilities & Equity	5.65	4.19	7.22	0.01	0.21
Shares Outstanding(shares)	0.01	0.00	0.74	0.65	–
Deposits	–	–	–	–	1.15

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 561.8%

Financial strength

Current ratio: 0.13
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 3.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.00
Dividend yield: –